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Abstract
Background: The escalating global epidemic of obesity is of worldwide concern because of its association with
serious negative effects on health. The technical difficulty of rectal cancer surgery is exacerbated in obese patients,
which may compromise outcomes. High-quality, relevant evidence is limited. This meta-analysis aims to assess the
outcomes of rectal cancer surgery in obese and nonobese patients.
Methods: The electronic databases Pubmed, Medline, Embase, Web of Science, and the Cochrane Library were
used to search for articles that evaluated the outcomes of rectal cancer surgery in obese and nonobese patients.
Fixed-effects and random-effects models were used to calculate the combined overall effect sizes of pooled data.
Data are presented as odds ratios (OR) or weighted mean differences (WMD) with 95 % confidence intervals (CIs).
Results: Ten appropriate observational studies were identified from 290 published articles. In the obese group,
conversion rates (OR 2.78; 95 % CI 1.67–4.61), overall morbidity (OR 1.36; 95 % CI 1.25–1.47), anastomotic leak (OR
3.94; 95 % CI 1.88–8.24), wound infection (OR 2.22; 95 % CI 1.47, 3.36), and pulmonary events (OR 2.10; 95 % CI 1.18,
3.74) were all significantly increased. For pathological results, no statistical differences in the number of harvested
lymph nodes and the positive margin were noted between the two groups.
Conclusions: Based on a meta-analysis, obesity increases the conversion rate and postoperative morbidity of rectal
cancer surgery but does not influence pathological results.
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Background
Over the past few decades, obesity has become a global
epidemic. As a result, there are many obese patients in
most clinic practices, and in the USA, they constitute a
third of all adult patients [1]. Body mass index (BMI), a
good indicator of total body fat, is associated with ad-
verse outcomes including metabolic, cardiovascular,
musculoskeletal, neurologic, respiratory, and gastrointes-
tinal disturbances, which can adversely affect surgical
outcomes [2]. Furthermore, perhaps because of its etio-
logical association with colorectal cancer, obesity is com-
mon in patients with this disease [3]. However, whether
a higher BMI can compromise surgical outcomes in pa-
tients with rectal cancer is unclear.
Rectal cancer surgery presents unique challenges; the
limited size of the pelvic cavity, necessity for extensive
yet precise dissection, and the proximity of other major
anatomic structures, all contribute to a complication rate
that has been reported at 30 to 50 %, substantially higher
than the 10 to 12 % cited for general surgery procedures
overall [4–6]. High BMI may be assumed to increase the
technical difficulty of rectal cancer surgery. The limiting
pelvic cavity can be further restricted by visceral adipos-
ity, a bulky mesentery can reduce mobility, and a thick-
ened abdominal wall can complicate ostomy formation
[6]. Although many surgeons acknowledge the chal-
lenges of rectal cancer surgery in the obese, the exact
impact of obesity on outcomes for rectal cancer surgery
remains controversial. Some studies suggested that pa-
tients with higher BMI had significantly more conver-
sions to an open procedure, more postoperative
complications, and a higher morbidity rate after rectal
cancer resection, whereas others yielded conflicting
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results [7, 8]. In addition, whether higher BMI would
have an adverse impact on pathological results is still de-
bated. In this study, we conducted a comprehensive
meta-analysis of published studies to derive a summary
estimate of the associations between obesity and out-
comes for rectal cancer surgery.
Methods
Study selection
This meta-analysis was conducted and reported accord-
ing to the MOOSE guidelines [9]. Our search strategy
was performed in the databases of PubMed/Medline,
Embase, Web of Science, and the Cochrane Library until
December 2014 to identify the eligible observational
studies that evaluated the outcomes of rectal cancer sur-
gery in obese and nonobese patients. Search items in-
cluded “obesity” or “obese” or “body mass index (BMI)”
and “rectal cancer” or “rectal carcinoma” or “laparos-
copy” or “resection” or “rectal surgery.” Only studies that
were conducted on humans and published in the English
language were considered for inclusion. We then
searched the reference lists of all relevant articles re-
trieved from the computerized database search to find
other potentially relevant articles. When the same pa-
tient population was included in several publications,
only the results from the most recent or most complete
study were used in the present meta-analysis.
Data extraction
Two of this study’s authors (Y. Qiu and Q.X. Liu) inde-
pendently extracted the data from all eligible studies. If
these two authors could not reach a consensus, disagree-
ments were discussed and resolved by a third author
(G.Q. Chen). The following variables were recorded: last
name of the first author, publication year, country in
which the study was performed, participant characteris-
tics, sample size, study design, inclusion and exclusion
criteria, and outcomes. Considering the observational
study design of the included studies, the Newcastle-
Ottawa Scale (NOS) was obtained to assess the meth-
odological quality of the included studies. It assessed the
patient selection, comparability of the study groups, and
the outcomes. A maximum of 9 was scored for a study
and the study with over 6 would be regarded as relative
high-quality [10].
Criteria for inclusion and exclusion
The following inclusion criteria were used for the
present meta-analysis: (1) outcomes of rectal cancer sur-
gery in obese and nonobese patients were compared; (2)
BMI was used to determine obesity; and (3) at least one
of the perioperative outcomes or pathological results
(see below) and the standard deviation for the mean for
continuous outcomes of interest were reported or could
be calculated. Case reports, letters, editorials, comments,
reviews, and abstracts with insufficient details to meet
the inclusion criteria were excluded. Differences in clas-
sifications of obesity might affect homogeneity. All of
the studies used BMI as a measure of obesity and non-
obese. According to the recommendation of the WHO,
the categorical definition of obesity used here was a BMI
of ≥30 kg/m2, and BMI <30 kg/m2 was considered nono-
besity [11].
Clinical outcomes of surgery for rectal cancer
♦ Operative outcome: conversion rate.
♦ Postoperative outcomes: overall morbidity, ileus,
wound infection, pulmonary events, deep venous
thrombosis, anastomotic leak, intra-abdominal abscess,
intra-abdominal hematoma, fistula, reoperation, post-
operative mortality, cardiac complications, renal failure,
sexual dysfunction, and bladder dysfunction.
♦ Pathological results: the positive margin and the
number of harvested nodes.
Statistical analysis
We analyzed dichotomous variables using an estimation
of the odds ratios (OR) with a 95 % confidence interval
(95 % CI) and continuous variables using a weighted
mean difference (WMD) with a 95 % CI. The pooled ef-
fect was calculated using a fixed-effects or random-
effects model. Statistical heterogeneity was evaluated
through the use of χ2 and I2 statistics. We considered
heterogeneity to be present if the I2 statistic was >50 %.
P < 0.05 was considered to be significant.
Results
Search results and study characteristics
A total of 290 articles were initially identified. The titles
and abstracts were reviewed to exclude the irrelevant
studies. We identified 45 potentially eligible articles that
evaluated the impact of obesity on the outcomes of rec-
tal cancer surgery. Finally, 10 studies complied with all
inclusion criteria [4, 7, 8, 12–18]. Figure 1 provides a
flow diagram of the search.
The characteristics of the included studies are shown
in Table 1. A total of 14,489 patients (obese 3660, non-
obese 10,829) from 10 studies were included. The sam-
ple size of each study varied from 26 to 11,995 patients.
Of the included studies, six studies were conducted in
the USA [4, 8, 13, 15, 16, 18], two in France [7, 14], one
in Turkey [17], and one in Australia [12]. All of the stud-
ies used BMI as a measure of obesity and nonobesity;
however, the cutoff points used to categorize BMI varied
among the studies. Four studies split BMI into at least
three tiers: (1) normal weight, BMI 18.5–24.9 or 20–24.9
or <25; (2) overweight, BMI 25–29.9; and (3) obese,
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BMI ≥ 30 [8, 13, 14, 17]. The remaining studies assessed
BMI as obesity (BMI ≥ 30) versus nonobesity (BMI < 30).
In these studies, patients in the two groups were
matched for age, gender, American Society of Anesthesi-
ologists (ASA) score, diagnosis, and surgical procedure
performed. Moreover, according to the NOS, all the in-
cluded studies belonged to a high-quality class (NOS
score ≥ 6).
Meta-analysis of the conversion rates
With respect to operative outcome, four studies reported
the conversion rate. The conversion rate was significantly
higher in obese patients than in nonobese patients
(P < 0.001; Fig. 2).
Meta-analysis of the postoperative outcomes
The main results of the meta-analysis are outlined in
Table 2. Our estimated pooled OR clearly shows that obes-
ity increased the risk of postoperative morbidity (P < 0.001;
Fig. 2). Anastomotic leak is a major concern in obese pa-
tients because they may experience more intraoperative
technical difficulties and comorbidities. The anastomotic
leak rate was significantly higher in obese patients than in
nonobese patients (P < 0.001; Fig. 2). In addition, wound
Fig. 1 Flow diagram of studies identified, included, and excluded
Table 1 Characteristics of the 10 selected studies included in the meta-analysis
Study Year Country Study size Group (OB/NOB) NOS Matching
Bokey et al. [12] 2014 Australia 255 95/160 8 1, 2, 4, 5
Smith et al. [13] 2014 USA 11,995 3050/8945 6 4, 5
Denost et al. [14] 2013 France 490 47/443 7 1, 3, 4, 5
Aytac et al. [15] 2013 USA 471 157/314 9 1–5
Clark et al. [16] 2013 USA 96 39/57 6 2, 4
Oyasiji et al. [8] 2012 USA 26 7/19 7 1, 3, 4,
Karahasanoglu et al. [17] 2011 Turkey 100 14/86 7 1, 2, 4, 5
Ballian et al. [4] 2010 USA 254 68/186 9 1–5
Chern et al. [18] 2010 USA 592 159/433 8 1, 2, 4, 5
Bege et al. [7] 2009 France 210 24/186 6 1, 2, 4, 5
NOS Newcastle-Ottawa scale, OB obese, NOB nonobese
1 = age; 2 = gender; 3 = American Society of Anesthesiologists score; 4 = diagnosis; 5 = surgical procedures
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infection (P < 0.001; Fig. 2) and pulmonary events (P =
0.012) were significantly higher in the obese group.
However, there was no significant difference between
the obese and nonobese groups for intra-abdominal ab-
scess, deep venous thrombosis, intra-abdominal
hematoma, fistula, reoperation, cardiac complication,
renal failure, sexual dysfunction, and bladder dysfunc-
tion. Moreover, our estimated pooled OR shows that
there was no significant difference between the two
groups for postoperative mortality (P > 0.05).
Meta-analysis of pathological results
No statistical difference was found between the two
groups in terms of the number of harvested lymph
nodes (P > 0.05). Pooled analysis for a positive margin
showed a prevalence of 19 of 472 (4.0 %) in the obese
group vs. 61 of 1079 (5.7 %) in the nonobese group,
without reaching statistical significance (P > 0.05).
Discussion
As the prevalence of being overweight and obesity has
grown in Western countries, its potential effects on out-
comes after abdominal surgery have received increasing
attention. In obese patients, rectal resection for malig-
nancy is clearly technically more difficult [19]. Most of
the studies included in this analysis showed a signifi-
cantly higher rate of conversion to laparotomy in an
obese group (28.3 %) than in a nonobese group (13.6 %).
These difficulties are primarily explained by problems of
exposure (layering of intestinal loops, volume of mesor-
ectum) and dissection difficulties due to the thickness of
fat tissue, particularly in cases of visceral obesity. More-
over, the bulky mesentery is vulnerable to laceration and
bleeding; therefore, using nontraumatic forceps to ma-
nipulate the bowel mesentery is both important and ne-
cessary [17]. Laceration due to traction of the mesentery
may result in unacceptable bleeding, which makes the
operation field chaotic. Unclear anatomy, intraoperative
hemorrhage, intra-abdominal adhesions, and bowel per-
foration were reported to be the common causes for
conversion in obese patients [20]. Moreover, other au-
thors have found that male gender, BMI, and location of
the rectal cancer were independent risk factors for con-
version [21].
The results from our overall meta-analysis pointed to
an association of obesity with increased morbidity in pa-
tients undergoing rectal cancer surgery. This observation
is congruent with earlier studies that have associated
obesity with greater technical difficulty and increased
surgical morbidity in laparoscopic colorectal cancer
Fig. 2 Forest plot displaying the results of the meta-analysis on conversion rates, overall morbidity, anastomotic leak, and wound infection
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resection [22]. In our study, obese group was proved to
be a risk factor for wound infection. Wick et al. [23] also
found that for patients undergoing colectomy, obesity
increases the risk of developing a postoperative surgical
site infection (SSI) by 60 %, with a cost in excess of
$17,000. In fact, SSI can be difficult to prevent in an
obese patient. This increased risk has been attributed to
decreased oxygen tension in adipose tissue, tissue
trauma, immune impairment, greater wound area, defi-
ciencies in collagen synthesis, and prolonged surgery
[24]. In addition, adiposity can affect the tissue concen-
trations of preoperative antibiotics [25]. Reducing infec-
tions by increasing antibiotic dosing and broadening the
antibiotic spectrum during surgery may be possible.
Another important finding of the present analysis was
that rate of anastomotic leak was significantly higher in
the obese group (8.0 vs. 2.2 %, P < 0.001). Anastomotic
leak is still the most dreaded surgical complication in
colorectal surgery. This complication often results in re-
operation and the need for a temporal or definitive
stoma and consequently has a significant impact on the
patient’s quality of life [26]. A retrospective analysis of
272 patients undergoing resection for rectal cancer
found that a low-level anastomosis (≤5 cm below the
anal verge) was an independent factor for the develop-
ment of anastomotic leakage. In a second analysis of low
anastomoses, obesity was the strongest risk factor for
leakage; obese patients with a low anastomosis were
more than twice as likely to experience a leak than were
nonobese patients with a low anastomosis [27]. This
finding may be explained by the fact that adiposity can
affect the access of linear staplers to the distal rectum in a
narrow pelvis, insertion of the stapler, or cephalad traction
on the rectum [19, 28]. However, some multicenter stud-
ies have shown that surgeon-related variables could be
risk factors for leakage [27, 29, 30]. Given these problems,
surgeons must consider several factors that make anasto-
mosis safe: bowel preparation, pelvic hemostasis, anasto-
motic tension, complete doughnuts, and intraoperative
testing of the anastomosis.
Interestingly, we found that obese patients had higher
incidence of pulmonary events when compared with non-
obese patients. Under general anesthesia, body mass is an
important determinant of vital capacity (VC), oxygenation,
and respiratory mechanics, mainly affecting functional
residual capacity (FRC) [31]. After a variety of surgi-
cal procedures, obese patients were found to have
greater declines in VC and were more likely to have
Table 2 Meta-analysis of the impact of obesity on outcomes after rectal cancer surgery
Outcome of interest No. of studies Events OR/WMD 95 % CI P value I2 (%)
Obese (%) Nonobese (%)
Operative outcomes
Conversion rates 4 [6, 7, 13, 16] 26/92 (28.3 %) 100/734 (13.6 %) 2.78 1.67, 4.61 <0.001 41.3
Postoperative outcomes
Overall morbidity 7 [6, 7, 12, 13, 15–17] 1320/3259 (40.5 %) 3264/9911 (32.9 %) 1.36 1.25, 1.47 <0.001 0
Mortality 8 [6, 7, 11–14, 16, 17] 34/3472 (1.0 %) 109/10,329 (1.0 %) 0.95 0.65, 1.39 0.780 0
Ileus 4 [6, 7, 13, 14] 28/306 (9.2 %) 47/936 (5.0 %) 1.33 0.81, 2.20 0.260 49.2
Wound infection 7 [6, 7, 11, 13–16] 50/383 (13.1 %) 58/1265 (4.6 %) 2.22 1.47, 3.36 <0.001 0
Pulmonary events 5 [6, 7, 11, 14, 16] 23/297 (7.7 %) 28/765 (3.7 %) 2.10 1.18, 3.74 0.012 12.1
Deep venous thrombosis 2 [11, 14] 7/252 (2.8 %) 14/474 (3.0 %) 0.97 0.38, 2.43 0.941 0
Anastomotic leak 4 [7, 11, 14, 16] 20/250 (8.0 %) 12/539 (2.2 %) 3.94 1.88, 8.24 <0.001 0
Intraabdominal abscess 5 [7, 11, 13, 14, 16] 19/320 (5.9 %) 77/1022 (7.5 %) 1.10 0.65, 1.89 0.715 45.1
Intraabdominal haematoma 2 [11, 13] 5/142 (3.5 %) 18/603 (3.0 %) 0.65 0.24, 1.73 0.387 84
Fistula 3 [6, 11, 14] 5/276 (1.8 %) 27/660 (4.1 %) 1.15 0.40, 3.28 0.797 0
Reoperation 4 [6, 7, 11, 14] 14/283 (5.0 %) 46/679 (6.8 %) 0.79 0.43, 1.47 0.466 0
Cardiac complication 2 [11, 14] 19/252 (7.5 %) 29/474 (6.1 %) 1.17 0.63, 2.17 0.612 0
Renal failure 3 [7, 11, 14] 2/259 (0.8 %) 2/493 (0.4 %) 2.11 0.40, 11.03 0.378 0
Sexual dysfunction 2 [14, 16] 1/171 (0.6 %) 5/400 (1.3 %) 0.70 0.12, 4.25 0.699 0
Bladder dysfunction 2 [14, 16] 0/171 (0.0 %) 2/400 (0.5 %) 1.05 0.11, 10.27 0.965 0
Pathological results
Positive margin 5 [7, 11, 14, 17, 18] 19/472 (4.0 %) 61/1079 (5.7 %) 0.71 0.42, 1.20 0.197 0
Number of harvested nodes 5 [6, 11, 15, 17, 18] 0.07 −0.69, 0.83 0.852 0
OR odds ratio, WMD weighted mean difference, CI confidence interval
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clinically significant pneumonia, atelectasis, and hyp-
oxemia [24, 32]. Hence, the incidence of pulmonary
complications was understandably more common in
obese patients.
Obesity has been identified as an independent risk fac-
tor for postoperative ileus in some studies [33, 34]. A re-
cent meta-analysis showed that obese patients had a
significant higher rate of ileus after laparoscopic colec-
tomy [22]. One might have expected to see an increase
in the rate of ileus in the obese group in our study.
However, results of this study showed that the incidence
of the postoperative ileus did not differ significantly be-
tween the two groups. This result can in part be ex-
plained by the different operative scopes for colectomy
and proctectomy. Alternatively, there was evidence of
heterogeneity among the studies, most likely as a result
of differences in receiving neoadjuvant chemotherapy
among patients, tumor location in the rectum, and the
learning curve for surgeons performing rectal surgery.
The presence of lymph node metastasis is important
for predicting clinical outcomes in patients who have
undergone radical surgery for rectal cancer and directing
adjuvant therapy. Most previous reports of open and
laparoscopic proctectomy have not shown an adverse ef-
fect for obesity on lymph node yield but have varied
greatly in the number of nodes retrieved [35, 36]. This
study showed no difference in the median number of
lymph nodes harvested in each of the groups. Further-
more, a negative circumferential resection margin
(CRM) was of crucial importance because radiotherapy
could not compensate for a positive margin [37]. When
the principles of total mesorectal excision are followed,
CRM positivity should be minimized. We did not detect
a higher rate of positive CRM in obese compared with
nonobese rectal cancer patients in this meta-analysis.
Therefore, the results suggest that obesity does not dir-
ectly influence the pathological security.
The data analyzed in this meta-analysis suggest that
rectal cancer surgery is more difficult in obese patients
without affecting the pathological results. Nevertheless,
these results should be interpreted cautiously because
our analysis has several limitations. First, our analyses
are of observational studies, and the inherent limitations
of such studies may affect our findings. In the study se-
lection process, we used the Western definition of obes-
ity (BMI ≥ 30 kg/m2). Thus, some studies were excluded
because they used different definition and classification
of obesity. Second, differences in the study populations,
assessment of covariates, and exposure variables may
contribute to heterogeneity across the studies and thus
affect the pooled estimates. Third, there is a lack of
long-term data to quantitatively demonstrate the sur-
vival for patients with rectal cancer, which is clearly a
controversial point when comparing prognosis in obese
and nonobese patients [29]. Further analyses would have
been of extreme interest, such as endoanal ultrasound
and an anal sphincter assessment, low anterior resection
syndrome score, and R0 achievement, but the lack of
sufficient data on these topics did not permit us to
analyze these factors further.
Conclusions
The present study involving 14,489 subjects represents
the first meta-analysis comparing the results of surgery
for rectal cancer in obese and nonobese patients. This
study shows that rectal cancer surgery is more difficult
in obese patients, with an increase in the conversion to
laparotomy and overall relevant morbidity and without
an effect on the pathological results.
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